TVWM
PFE icon

Tower View Wealth Management’s Pfizer PFE Stock Holding History

Tower View Wealth Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30.4K Buy
1,261
+21
+2% +$549 0.01% 116
2026
Q1 		$34.8K Buy
1,240
+19
+2% +$506 0.02% 105
2025
Q4 		$30.4K Buy
1,221
+20
+2% +$504 0.02% 97
2025
Q3 		$30.6K Buy
1,201
+21
+2% +$518 0.02% 96
2025
Q2 		$28.6K Buy
1,180
+20
+2% +$466 0.01% 110
2025
Q1 		$29.4K Buy
1,160
+18
+2% +$471 0.02% 92
2024
Q4 		$30.3K Buy
1,142
+19
+2% +$515 0.02% 95
2024
Q3 		$32.5K Buy
1,123
+16
+1% +$467 0.02% 93
2024
Q2 		$31K Buy
1,107
+17
+2% +$468 0.02% 93
2024
Q1 		$30.3K Buy
1,090
+17
+2% +$472 0.02% 95
2023
Q4 		$31K Sell
1,073
-843
-44% -$25.5K 0.02% 93
2023
Q3 		$64K Buy
1,916
+870
+83% +$30.8K 0.04% 71
2023
Q2 		$38K Buy
1,046
+11
+1% +$428 0.03% 83
2023
Q1 		$42K Buy
1,035
+10
+1% +$432 0.03% 85
2022
Q4 		$53K Buy
1,025
+8
+0.8% +$384 0.04% 80
2022
Q3 		$45K Buy
1,017
+9
+0.9% +$437 0.03% 82
2022
Q2 		$53K Buy
1,008
+8
+0.8% +$408 0.04% 79
2022
Q1 		$52K Hold
1,000
– – 0.03% 101
2021
Q4 		$59K Hold
1,000
– – 0.03% 101
2021
Q3 		$43K Buy
+1,000
New +$44.3K 0.02% 107
2018
Q4 		– Sell
-1,476
Closed -$62K – 154
2018
Q3 		$62K Hold
1,476
– – 0.05% 85
2018
Q2 		$51K Hold
1,476
– – 0.05% 86
2018
Q1 		$50K Sell
1,476
-58
-4% -$1.99K 0.05% 87
2017
Q4 		$53K Buy
+1,534
New +$52.3K 0.05% 89

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Tower View Wealth Management's PFE Position: Q2 2026 in Review

Tower View Wealth Management increased its Pfizer (PFE) stake by 1.7% in Q2 2026, buying an estimated $549 and bringing the position to 1,261 shares worth $30.4K. The position accounts for 0.01% of the portfolio, ranked #116.

Tower View Wealth Management first reported a position in PFE in Q4 2017 and has held it in 24 quarters since. The position peaked at $64K in Q3 2023. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Tower View Wealth Management held 1,261 shares of Pfizer worth $30.4K as of Q2 2026.
  • Tower View Wealth Management bought 21 Pfizer shares in Q2 2026, an estimated $549.
  • Pfizer made up 0.01% of Tower View Wealth Management's portfolio in Q2 2026, its #116 holding.
  • Tower View Wealth Management first reported a position in Pfizer in Q4 2017 and has held it in 24 quarters since.
  • Tower View Wealth Management's Pfizer position peaked at $64K in Q3 2023.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Tower View Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.